Conditions: Actinic Keratosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 24
Healthy volunteers: no

Brief summary:
This trial will be conducted to explore the biological effects in the skin following treatment with PEP005 Gel, 0.05% administered for two consecutive days, assessed by reflectance confocal microscopy.

Detailed description:

Arms:
arm 1: active ingredient of PEP005: Ingenol mebutate arm 2: Vehicle of PEP005 Gel

Interventions: intervention 1: Ingenol mebutate intervention 2: Placebo Gel
Intervention descriptions: intervention 1: 0.05% Ingenol mebutate Gel once daily for 2 consecutive days intervention 2: Gel vehicle of PEP005

Protocol document: